FibroGenesis is a regenerative medicine company developing an innovative solution for degenerative disc disease using human dermal fibroblasts. Currently, FibroGenesis holds 150+ U.S. and international issued patents issued/pending. FibroGenesis represents the next generation of medical advancement in cell therapy.
View Top Employees from SpinalCyte, LLCWebsite | http://www.spinalcyte.com |
Revenue | $1 million |
Employees | 3 (0 on RocketReach) |
Address | 16815 Royal Crest Dr, Houston, Texas 77030, US |
Phone | (281) 461-6211 |
Fax | (281) 461-6213 |
Industry | Biotechnology Research, Drug Manufacturing & Research, Medical, Pharmaceuticals, Health Care, Healthcare, Therapeutics |
Competitors | CollPlant, Lineage Cell Therapeutics, Pharvaris, VIDEREGEN LIMITED, ViaCyte |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 5417 Companies, NAICS Code 541 Companies, NAICS Code 54 Companies, NAICS Code 541714 Companies, NAICS Code 54171 Companies |
Looking for a particular SpinalCyte, LLC employee's phone or email?
The SpinalCyte, LLC annual revenue was $1 million in 2024.
SpinalCyte, LLC is based in Houston, Texas.
The NAICS codes for SpinalCyte, LLC are [5417, 541, 54, 541714, 54171].
The SIC codes for SpinalCyte, LLC are [873, 87].